99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
Human cells building 'molecular highways' captured for first time

Human cells building 'molecular highways' captured for first time

FEBRUARY 1, 2024byCenter for Genomic Regulationγ-TuRC starting the nucleation process (left) vs. γ-TuRC closing (right). Once closed, thhe foundation is set and tubulins can be added to make the

Human cells building 'molecular highways' captured for first time

FEBRUARY 1, 2024byCenter for Genomic Regulationγ-TuRC starting the nucleation process (left) vs. γ-TuRC closing (right). Once closed, thhe foundation is set and tubulins can be added to make the
Researcher explores sex-specific features of HIV

Researcher explores sex-specific features of HIV

FEBRUARY 6, 2024by Linell Smith,Johns Hopkins UniversityEileen Scully. Credit: Johns Hopkins MedicineEarly in her career, Johns Hopkins physician-scientist Eileen Scully began to explore ways th

Researcher explores sex-specific features of HIV

FEBRUARY 6, 2024by Linell Smith,Johns Hopkins UniversityEileen Scully. Credit: Johns Hopkins MedicineEarly in her career, Johns Hopkins physician-scientist Eileen Scully began to explore ways th
Patient images are missing in studies on atopic dermatitis

Patient images are missing in studies on atopic dermatitis

byUniversity of GothenburgPRISMA flow chart. PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Credit:Journal of Dermatological Treatment(2024). DOI: 10.108

Patient images are missing in studies on atopic dermatitis

byUniversity of GothenburgPRISMA flow chart. PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Credit:Journal of Dermatological Treatment(2024). DOI: 10.108
HIV: Early treatment is one key to remission

HIV: Early treatment is one key to remission

JANUARY 23, 2024 Editors' notesbyPasteur InstituteThe anti-SIV antibody levels after treatment interruption are associated with the magnitude of antigen stimulation. Kinetics of plasma anti-

HIV: Early treatment is one key to remission

JANUARY 23, 2024 Editors' notesbyPasteur InstituteThe anti-SIV antibody levels after treatment interruption are associated with the magnitude of antigen stimulation. Kinetics of plasma anti-
Developing standards for organ-on-a-chip research

Developing standards for organ-on-a-chip research

FEBRUARY 22, 2024by Jennifer Lauren Lee,National Institute of Standards and TechnologyOrgan-on-a-chip devices use tiny structures called microfluidic channels to bring small, controlled amounts

Developing standards for organ-on-a-chip research

FEBRUARY 22, 2024by Jennifer Lauren Lee,National Institute of Standards and TechnologyOrgan-on-a-chip devices use tiny structures called microfluidic channels to bring small, controlled amounts
A step closer to treatment for severe bacterial infections and sepsis

A step closer to treatment for severe bacterial infections and sepsis

JANUARY 10, 2024byLund UniversityThe illustration depicts how the researchers' peptide treatment (pink) binds to both receptors that can detect bacterial substances (green) and to bacterial

A step closer to treatment for severe bacterial infections and sepsis

JANUARY 10, 2024byLund UniversityThe illustration depicts how the researchers' peptide treatment (pink) binds to both receptors that can detect bacterial substances (green) and to bacterial
Innovative therapies for ischemic stroke: Novel bicarbonate-sensing G protein-coupled receptor shows promise

Innovative therapies for ischemic stroke: Novel bicarbonate-sensing G protein-coupled receptor shows promise

FEBRUARY 27, 2024by Juntendo University Research Promotion CenterGPR30 in brain microvasculature responds to bicarbonate, and its deficiency protects against ischemia-reperfusion injury, reducing neur

Innovative therapies for ischemic stroke: Novel bicarbonate-sensing G protein-coupled receptor shows promise

FEBRUARY 27, 2024by Juntendo University Research Promotion CenterGPR30 in brain microvasculature responds to bicarbonate, and its deficiency protects against ischemia-reperfusion injury, reducing neur
Adding diversity to your research process: A new system

Adding diversity to your research process: A new system

by Hoag Levins,University of PennsylvaniaCredit: University of PennsylvaniaInsufficient diversity in clinical trials and other research cohorts is widely recognized as one of American health car

Adding diversity to your research process: A new system

by Hoag Levins,University of PennsylvaniaCredit: University of PennsylvaniaInsufficient diversity in clinical trials and other research cohorts is widely recognized as one of American health car
A potential method for interrupting the misfolding of tau protein that underlies neurodegenerative disease

A potential method for interrupting the misfolding of tau protein that underlies neurodegenerative disease

by Sonia Fernandez,University of California - Santa BarbaraInvestigation of the effect of VHH Z70 nanobody on jR2R3 P301L-induced tau fibrillization in cells. Credit:Proceedings of the Nat

A potential method for interrupting the misfolding of tau protein that underlies neurodegenerative disease

by Sonia Fernandez,University of California - Santa BarbaraInvestigation of the effect of VHH Z70 nanobody on jR2R3 P301L-induced tau fibrillization in cells. Credit:Proceedings of the Nat
Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their pos

Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their pos
'It's the greatest living experiment': Pitt Men's Study marks 40 years of AIDS research

'It's the greatest living experiment': Pitt Men's Study marks 40 years of AIDS research

by Anya Sostek, Pittsburgh Post-GazetteCredit: Pixabay/CC0 Public DomainIn a Pittsburgh hospital in the early 1980s, Charles Rinaldo saw a young, previously healthy gay man critically ill with a virus

'It's the greatest living experiment': Pitt Men's Study marks 40 years of AIDS research

by Anya Sostek, Pittsburgh Post-GazetteCredit: Pixabay/CC0 Public DomainIn a Pittsburgh hospital in the early 1980s, Charles Rinaldo saw a young, previously healthy gay man critically ill with a virus
Drugs of the future will be easier and faster to make, thanks to mRNA—after researchers work out a few remaining kinks

Drugs of the future will be easier and faster to make, thanks to mRNA—after researchers work out a few remaining kinks

JANUARY 5, 2024by Li Li,The ConversationThis is a computer graphic of an RNA molecule. Credit: Richard Feldmann/WikipediaVaccines have been reliably and affordably protecting people from disease

Drugs of the future will be easier and faster to make, thanks to mRNA—after researchers work out a few remaining kinks

JANUARY 5, 2024by Li Li,The ConversationThis is a computer graphic of an RNA molecule. Credit: Richard Feldmann/WikipediaVaccines have been reliably and affordably protecting people from disease